Adnexus Therapeutics is a startup based in the United States, most recent round Acquired, 1 tracked investor.
Based in the United States, Adnexus Therapeutics is a startup. Adnexus Therapeutics has been acquired. Brouky records 1 investor associated with the company.
Adnexus Therapeutics developed Adnectins, a class of biologic therapeutics based on human fibronectin, and advanced biologics and antibody candidates for treatment of disease. The company was founded in 2003 and was acquired by Bristol-Myers Squibb in 2007.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.